Skip to content

13F-HR filed by TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 53 holding rows worth $499,884,000.

Accession
0001214659-22-006993
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 53 entries on the cover page, a total value of $499,884,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $499,884,000 with VALUE read as thousands by filing date, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ANAPTYSBIO INC032724106COM2,628,678$65,033,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK700,000$42,833,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 29,607,934$41,026,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM937,500$30,169,000thousands by filing date
BIO RAD LABS INC090572207CL A40,000$22,529,000thousands by filing date
HERON THERAPEUTICS INC427746102COM3,720,000$21,278,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,265,900$20,077,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW2,573,744$15,674,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR250,000$15,505,000thousands by filing date
HARMONY BIOSCIENCES HLDGS IN413197104COM300,000$14,595,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK467,702$13,952,000thousands by filing date
IMMUNOCORE HLDGS PLC ADS45258D105ADR385,600$11,529,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM750,000$9,683,000thousands by filing date
SIERRA ONCOLOGY INC82640U404CMN300,000$9,615,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM648,269$9,555,000thousands by filing date
INSPIRATO INCORPORATED45791E107COM855,368$8,502,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM3,000,000$8,280,000thousands by filing date
ALLAKOS INC01671P100COM1,323,393$7,543,000thousands by filing date
BLUEBIRD BIO INC09609G100COM1,550,000$7,518,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock200,000$7,408,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK1,500,000$7,140,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM100,000$7,118,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR40,000$6,822,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM200,000$6,312,000thousands by filing date
ATYR PHARMA INC002120202COM NEW1,113,453$5,957,000thousands by filing date
BIOATLA INC09077B104COM1,100,000$5,500,000thousands by filing date
2SEVENTY BIO INC COMMON STOCK901384107Stock300,000$5,118,000thousands by filing date
CORVUS PHARMACEUTICALS INC221015100COM3,101,709$5,087,000thousands by filing date
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK300,000$5,046,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A500,000$4,970,000thousands by filing date
GENFIT S A372279109ADS1,171,361$4,685,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM600,000$4,128,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW1,030,634$4,123,000thousands by filing date
BRC INC05601U113*W EXP 02/09/202805,900$3,602,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM468,750$3,553,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM2,350,000$3,196,000thousands by filing date
ASLAN PHARMACEUTICALS LTD04522R101ADR3,286,122$2,957,000thousands by filing date
Reviva Pharmaceuticals Holdings Inc76152G100Common Stock1,200,000$2,952,000thousands by filing date
NEKTAR THERAPEUTICS CMN STK640268958Cmn539,600$2,908,000thousands by filing dateput
NEKTAR THERAPEUTICS CMN STK640268908Cmn539,600$2,908,000thousands by filing datecall
VANDA PHARMACEUTICALS INC921659108COM256,696$2,903,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM100,000$2,811,000thousands by filing date
INSPIRATO INCORPORATED45791E115*W EXP 02/11/2021,400,000$2,716,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM430,037$2,318,000thousands by filing date
NKARTA INC65487U108COMMON STOCK200,000$2,276,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM1,250,000$2,188,000thousands by filing date
EQUILLIUM INC29446K106COM600,000$1,890,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS50,000$1,817,000thousands by filing date
ALECTOR INC014442107COMMON STOCK100,000$1,425,000thousands by filing date
TRITIUM DCFC LIMITEDQ9225T108ORDINARY SHARES124,186$1,247,000thousands by filing date
SKY HARBOUR GROUP CORPORATIO83085C115*W EXP 01/25/202459,611$694,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM214,898$653,000thousands by filing date
Tscan Therapeutics Inc89854M101COM200,000$560,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-22-006993this filing2022-05-16acceptance time not in the bulk data set